Covered recipient · General Payments record
DIVIJANI D PUTTAGUNTA
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2025
$2,283.17
- Reported across 136 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $639.95 | 34 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $242.50 | 13 |
| Abbott Laboratories | $95.45 | 4 |
| Amgen Inc. | $60.99 | 4 |
| GlaxoSmithKline, LLC. | $43.90 | 3 |
| Novo Nordisk AS | $36.42 | 2 |
| Madrigal Pharmaceuticals | $23.70 | 1 |
| Sumitomo Pharma America, Inc. | $23.44 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.58 | 1 |
| Gilead Sciences, Inc. | $19.79 | 1 |
| Otsuka America Pharmaceutical, Inc. | $19.69 | 1 |
| Amneal Pharmaceuticals LLC | $18.19 | 1 |
| Lundbeck LLC | $17.38 | 1 |
| ABBVIE INC. | $15.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (34)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.93 | 06/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240949524 | CMS |
| Abbott Laboratories | $24.25 | 09/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240970344 | CMS |
| Abbott Laboratories | $21.38 | 10/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241042404 | CMS |
| Abbott Laboratories | $24.89 | 12/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240833888 | CMS |
| ABBVIE INC. | $15.92 | 02/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203706697 | CMS |
| Amgen Inc. | $16.94 | 03/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228660386 | CMS |
| Amgen Inc. | $15.21 | 06/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228660384 | CMS |
| Amgen Inc. | $14.59 | 10/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227254584 | CMS |
| Amgen Inc. | $14.25 | 12/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227254582 | CMS |
| Amneal Pharmaceuticals LLC | $18.19 | 04/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1220546126 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.58 | 10/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222977055 | CMS |
| Gilead Sciences, Inc. | $19.79 | 10/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234530623 | CMS |
| GlaxoSmithKline, LLC. | $15.41 | 04/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190863874 | CMS |
| GlaxoSmithKline, LLC. | $13.83 | 06/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190601235 | CMS |
| GlaxoSmithKline, LLC. | $14.66 | 12/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190914031 | CMS |
| Lundbeck LLC | $17.38 | 09/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251837073 | CMS |
| Madrigal Pharmaceuticals | $23.70 | 10/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248300590 | CMS |
| Novo Nordisk Inc | $19.86 | 04/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189067668 | CMS |
| Novo Nordisk Inc | $16.56 | 06/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188352456 | CMS |
| Otsuka America Pharmaceutical, Inc. | $19.69 | 10/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227458668 | CMS |
| PFIZER INC. | $21.86 | 02/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231367181 | CMS |
| PFIZER INC. | $21.34 | 02/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231642801 | CMS |
| PFIZER INC. | $14.42 | 02/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231388185 | CMS |
| PFIZER INC. | $16.65 | 04/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231606593 | CMS |
| PFIZER INC. | $19.37 | 06/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231293838 | CMS |
| PFIZER INC. | $16.70 | 06/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231715178 | CMS |
| PFIZER INC. | $24.58 | 07/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228811904 | CMS |
| PFIZER INC. | $7.27 | 08/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229198674 | CMS |
| PFIZER INC. | $23.85 | 09/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229290041 | CMS |
| PFIZER INC. | $20.87 | 10/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229564793 | CMS |
| PFIZER INC. | $25.02 | 11/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229746023 | CMS |
| PFIZER INC. | $22.03 | 11/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229800806 | CMS |
| PFIZER INC. | $8.54 | 12/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229395496 | CMS |
| Sumitomo Pharma America, Inc. | $23.44 | 03/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1176707783 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.